Kea Bory, Alligood Tahroma, Manning Vincent, Raitt Merritt
Assistant Professor, Department of Emergency Medicine, Oregon Health & Science University School of Medicine, Mailcode CR114, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, 503-494-4430 (p), 503-494-8237 (f).
Research Associate, Department of Emergency Medicine, Oregon Health & Science University School of Medicine, Doctoral Student, Department of Public Health & Preventive Medicine, OHSU/PSU School of Public Health, Mailcode CR114, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, 503-494-4566.
Curr Emerg Hosp Med Rep. 2016 Sep;4(3):107-118. doi: 10.1007/s40138-016-0105-2. Epub 2016 Jul 6.
Atrial fibrillation (AF) is the most common arrhythmia encountered by clinicians. Clinical decision-making focuses on reducing ischemic stroke risk in AF patients; however, AF is also associated with an increased risk of acute coronary syndromes (ACS). Patients with ACS and concurrent AF are less likely to receive appropriate therapies and more likely to experience adverse outcomes than ACS patients in sinus rhythm (SR). Clinicians may be able to stratify ACS patients at increased risk of AF development based on clinical characteristics. Evidence supporting specific therapeutic options for prevention of ACS in AF patients or for prevention of AF in ACS patients is limited, however there is some evidence of differing effects among oral anticoagulant regimens in these populations. Investigations of the relationship of AF with the full spectrum of ACS are not well described and should be the focus of future research.
心房颤动(AF)是临床医生遇到的最常见心律失常。临床决策重点在于降低房颤患者的缺血性卒中风险;然而,房颤还与急性冠脉综合征(ACS)风险增加相关。与窦性心律(SR)的ACS患者相比,合并房颤的ACS患者接受适当治疗的可能性较小,且更易出现不良结局。临床医生或许能够根据临床特征对发生房颤风险增加的ACS患者进行分层。支持房颤患者预防ACS或ACS患者预防房颤的特定治疗方案的证据有限,不过有一些证据表明这些人群中不同口服抗凝方案的效果存在差异。房颤与整个ACS谱之间关系的研究描述尚不充分,应成为未来研究的重点。